000819 Yueyang Xingchang Petro-chemical
- 15.24
- -0.02-0.13%
Yueyang Xingchang Petro-chemical News
Research Report Nuggets 丨 Guolian Securities: The Yueyang Xingchang Huizhou project will soon be put into operation, and the profit of MTBE, the main business, is expected to strengthen
Yueyang Xing Chang (000819): The performance is in line with our expectations and the prospects for the rich metal polypropylene business are promising
Yueyang Xingchang (000819) In-depth Research Report: Refining and Fine Chemical Leaders Focus on Specialty Polypropylene in the Short Term
Yueyang Xingchang (000819): Q3 performance is in line with expectations, the first phase of the high-end polyolefin project will be put into operation next year
Yueyang Xingchang (000819): High-end polyolefin project with performance in line with expectations to be put into operation next year
[southwest Securities] Yueyang Xingchang: no, the main performance is reversed at the bottom.
Yueyang Xingchang (000819) comments on China News: no Ji Tailai's main performance reversal at the bottom
[Guoyuan Securities] Yueyang Xing Chang: Main business is improving, stomach disease vaccine program still needs to wait
[Huatai Securities] Yueyang Xingchang: Received “Oral Recombinant Helicobacter Pylori Vaccine” New Drug Certificate Review
[Oriental Securities] Yueyang's rise: the road ahead is bright and tortuous
[Huatai Securities] Yueyang Xing: Breaking the Cocoon and Waiting Before Going Out
[Citic Construction] S Yue Xingchang: the income may increase and the risk will gradually decrease.
[fortune Securities] S Yue Xingchang: stomach disease vaccine has a broad prospect or may become a biomedical company
[China Merchants] Yueyang Xingchang (000819): innovative Vaccine, Future profit doubles and value is undervalued
[Citic Construction Investment] Yueyang Xingchang: the development direction of the main business is gradually clear and the share reform is approaching.
【中信建投】岳阳兴长：风险投资进入收获期
Analysis
Price Target
No Data
